Abstract: Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.

Abstract: Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of capsaicin, wasabi, olive leaf extract, nicotinic acid, and copper gluconate.

Abstract: Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.

Abstract: Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of alpinia galanga, wasabi, olive leaf extract, nicotinic acid, and copper gluconate.

Abstract: Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of mango leaf extract, wasabi, olive leaf extract, nicotinic acid, and copper gluconate.

Abstract: The present invention extends to methods, systems, and computer program products for providing an online health assessment. The online health assessment collects information from an individual and applies conditional logic to the collected information to identify information to be included in a lifestyle, nutrition, and/or product plan for the individual.

Abstract: The present invention is directed to providing an online health assessment. The online health assessment collects information from an individual and uses the information to identify areas of a person's lifestyle, nutrition, and/or products that pose the greatest risk to future health. The online health assessment can also make recommendations for addressing the areas of greatest risk, as well as make lifestyle, nutrition, and/or product recommendations for assisting the person in improving his lifestyle to improve the areas of risk.

Abstract: The present invention provides an online health assessment that collects information from an individual and uses the information to recommend changes to the individual's lifestyle, nutrition, and/or products that will assist the individual to maintain or improve a current level of health.

Abstract: A display system is configured to produce a color image formed of a plurality of differently colored images and may include at least one light source that directs light along an optical path, and at least one filter having a given optical filter characteristic. The display system may be selectively operable in a first state in which the optical path does not pass through a first filter during production of the plurality of differently colored images to form a color image having a first optical characteristic, and in a second state in which the optical path passes through the first filter during production of the plurality of differently colored images to form a color image having a second optical characteristic different than the first optical characteristic.

Abstract: A system for balancing multiple memory buffer sizes includes a memory partitioned into a plurality of subgroups, each subgroup containing similarly sized buffers. The system further includes a memory manager which manages requests for buffer space by storing and accessing buffer steal history records in a buffer steal history queue.

Abstract: An electrolyte is described that represents a new composition of matter. This electrolyte contains alternating electronegative group III-VI elements connected with hydrocarbon or fluorocarbon linkages to form a polyalkyl or polyfluoroalkyl heteroatomic that is used in combination with magnesium ions. These materials can also be combined with magnesium salts or organometallic (metalloorganic) compounds to form a novel electrolyte for use in electrochemical systems, such as batteries. The new electrolytes exhibit magnesium cation diffusion and transport numbers that are equivalent to standard battery electrolytes, such as carbonates. The new electrolytes are nonflammable which represents a substantial advance in the state of the art, especially as it pertains to safety.

Abstract: Embodiments of modifying an optical characteristic of a screen are disclosed.

Abstract: Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented. The compounds of the invention have the generalized formulas: wherein r is 0-2, T is selected from and R40 is a mono- or bi-heterocyclic structure. These compounds are useful for inhibiting matrix metalloproteases and, therefore, combating conditions to which MMP's contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, comeal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibularjoint disease, demyelating diseases of the nervous system, tumor metastasis or degenerative cartilage loss following traumatic joint injury, and coronary thrombosis from athrosclerotic plaque rupture.

Abstract: A system for balancing multiple memory buffer sizes includes a memory partitioned into a plurality of subgroups, each subgroup containing similarly sized buffers. The system further includes a memory manager which manages requests for buffer space by storing and accessing buffer steal history records in a buffer steal history queue.

Abstract: A method for adjusting color of images displayed in ambient light. A signal may be sensed from a plurality of spectral regions of an ambient light source to define a sensed signature of the ambient light source. The sensed signature may be compared to predetermined signatures of candidate light sources to identify a candidate light source that corresponds to the ambient light source. Images may be created so that the images are modified by a predefined color adjustment for the candidate light source identified.

Abstract: An enzyme containing in-house digester unit for receiving and treating household waste material, which utilizes settling and biological treatment of solids and wastewater by means of organisms which digest the organic materials contained in the household waste thereby eliminating the need for any chemical treatment or processes.

Abstract: A composition and method for inhibiting corrosion of iron and steel in the presence of aqueous acid, especially concentrated hydrochloric acid comprising at least 5% by weight HCl, comprising an effective corrosion inhibiting amount of an alkenylphenone having the following structure: ##STR1## wherein R.sub.1 may be unsubstituted or inertly substituted aryl of 6 to about 10 carbons, and R.sub.2 and R.sub.3 may be the same or different and each may be hydrogen, halogen, or inertly substituted aliphatic of about 3 to about 12 carbons, and R.sub.2 may also be alkanol, ether, or unsubstituted or inertly substituted aryl of 6 to about 10 carbons, provided that the total number of carbons in said alkenylphenone does not exceed 16, and preferably including a surfactant, and a process of using this composition.